Fibrocell to Present at 2016 Cell & Gene Meeting on the Mesa
September 29, 2016 08:00 ET
|
Fibrocell Science, Inc.
EXTON, Pa., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (NASDAQ:FCSC) today announced that John Maslowski, Senior Vice President, Scientific Affairs of Fibrocell, will present at...
Fibrocell Completes Enrollment in NC1+ Cohort of Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
September 19, 2016 08:00 ET
|
Fibrocell Science, Inc.
EXTON, Pa., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC) today announced that two additional adult subjects were enrolled in the Phase I/II clinical trial of FCX-007...
Fibrocell Announces Closing of $18 Million Private Placement
September 08, 2016 09:29 ET
|
Fibrocell Science, Inc.
EXTON, Pa., Sept. 08, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC) today reported the receipt of $18.1 million of gross proceeds from the sale of convertible promissory notes and...
Fibrocell Announces Convertible Debt and Warrant Financing of Up to $25 Million
August 09, 2016 08:30 ET
|
Fibrocell Science, Inc.
EXTON, Pa., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC) today announced that it has terminated the previously announced underwritten public offering of common stock and...
Fibrocell Announces Proposed Public Offering of Common Stock and Warrants
August 08, 2016 16:30 ET
|
Fibrocell Science, Inc.
EXTON, Pa., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC) (Fibrocell) today announced that it intends to offer and sell shares of its common stock and related warrants to...
Fibrocell Reports Second Quarter 2016 Financial Results and Recent Operational Highlights
August 04, 2016 08:01 ET
|
Fibrocell Science, Inc.
EXTON, Pa., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC) today reported financial results for the second quarter ended June 30, 2016 and recent operational highlights....
Fibrocell to Host Conference Call and Webcast on Thursday, August 4, 2016 to Discuss Second Quarter 2016 Financial Results and Recent Operational Highlights
July 28, 2016 08:01 ET
|
Fibrocell Science, Inc.
EXTON, Pa., July 28, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC) will report financial results for the second quarter ended June 30, 2016 and recent operational highlights on...
Fibrocell Announces First Subjects Enrolled in Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
July 27, 2016 16:01 ET
|
Fibrocell Science, Inc.
EXTON, Pa., July 27, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC) today announced that the first two adult subjects were enrolled in the Phase I/II clinical trial of FCX-007 for...
Fibrocell to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
July 07, 2016 16:05 ET
|
Fibrocell Science, Inc.
EXTON, Pa., July 07, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (NASDAQ:FCSC) today announced that David Pernock, Chairman and Chief Executive Officer of Fibrocell, will present at Cantor...
Fibrocell Expects Significant Cost Savings from Wind-Down of azficel-T Operations
June 29, 2016 16:30 ET
|
Fibrocell Science, Inc.
EXTON, Pa., June 29, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC) today announced significant cost savings are expected from the wind-down of its azficel-T operations and that...